Review



disitamab vedotin (dv)  (RemeGen Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    RemeGen Ltd disitamab vedotin (dv)
    Major metabolic pathways of [ 3 H]-labelled <t>disitamab</t> <t>vedotin</t> in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue
    Disitamab Vedotin (Dv), supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin (dv)/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin (dv) - by Bioz Stars, 2026-02
    90/100 stars

    Images

    1) Product Images from "Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin"

    Article Title: Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin

    Journal: ADMET & DMPK

    doi: 10.5599/admet.2582

    Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue
    Figure Legend Snippet: Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

    Techniques Used: Clinical Proteomics



    Similar Products

    disitamab vedotin (dv)  (RemeGen Ltd)
    90
    RemeGen Ltd disitamab vedotin (dv)
    Major metabolic pathways of [ 3 H]-labelled <t>disitamab</t> <t>vedotin</t> in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue
    Disitamab Vedotin (Dv), supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin (dv)/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin (dv) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    disitamab vedotin dv  (RemeGen Ltd)
    90
    RemeGen Ltd disitamab vedotin dv
    Major metabolic pathways of [ 3 H]-labelled <t>disitamab</t> <t>vedotin</t> in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue
    Disitamab Vedotin Dv, supplied by RemeGen Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/disitamab vedotin dv/product/RemeGen Ltd
    Average 90 stars, based on 1 article reviews
    disitamab vedotin dv - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

    Journal: ADMET & DMPK

    Article Title: Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin

    doi: 10.5599/admet.2582

    Figure Lengend Snippet: Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

    Article Snippet: Disitamab vedotin (DV) was generated by RemeGen Co., Ltd., as described previously [ ].

    Techniques: Clinical Proteomics

    Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

    Journal: ADMET & DMPK

    Article Title: Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin

    doi: 10.5599/admet.2582

    Figure Lengend Snippet: Major metabolic pathways of [ 3 H]-labelled disitamab vedotin in rats/mice. P: plasma, represented by rate, % in B: bile, U: urine, F: faeces, representing and stool, respectively, represented by dose, %; T: tumour tissue, represented by rate, % of F: female and M: male rats with tumour tissue

    Article Snippet: Disitamab vedotin (DV), developed by RemeGen.

    Techniques: Clinical Proteomics